INVO Bioscience, Inc. (INVO) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated May 17, 2021, reports the issuance of a press release by INVO Bioscience, Inc. (formerly INVO Fertility, Inc.) announcing financial results for the three months ended March 31, 2021. The company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC under the symbol "INVO."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that the Q1 2021 results have been announced via a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 17, 2021) for actual Q1 2021 financial figures.
- Verify the company's name change from "INVO Fertility, Inc." to "INVO Bioscience, Inc."
- Confirm the status of the company as an emerging growth company (indicated as unchecked in the form).
- Check subsequent filings for any incorporation of the press release data into formal financial statements.